{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:06:49Z","timestamp":1792699609736,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10015-z","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T19:55:53Z","timestamp":1752177353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetic and pharmacodynamic characterization of remimazolam in older Japanese adults who underwent general anesthesia at early stage of infusion"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-1083","authenticated-orcid":false,"given":"Satoshi","family":"Ueshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serina","family":"Nagahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Hira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaneyuki","family":"Kawamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Kakumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"10015_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1213\/ANE.0b013e3181c3bfb2","volume":"110","author":"K Leslie","year":"2010","unstructured":"Leslie, K., Myles, P. S., Forbes, A. & Chan, M. T. The effect of bispectral index monitoring on long-term survival in the B-aware trial. Anesth. Analg. 110, 816\u2013822. https:\/\/doi.org\/10.1213\/ANE.0b013e3181c3bfb2 (2010).","journal-title":"Anesth. Analg"},{"key":"10015_CR2","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/ALN.0b013e3181d5e0a3","volume":"112","author":"MD Kertai","year":"2010","unstructured":"Kertai, M. D. et al. Association of perioperative risk factors and cumulative duration of low bispectral index with intermediate-term mortality after cardiac surgery in the B-Unaware trial. Anesthesiology 112, 1116\u20131127. https:\/\/doi.org\/10.1097\/ALN.0b013e3181d5e0a3 (2010).","journal-title":"Anesthesiology"},{"key":"10015_CR3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1017\/S0265021505231502","volume":"22","author":"G Basaranoglu","year":"2005","unstructured":"Basaranoglu, G., Erden, V., Delatioglu, H. & Saitoglu, L. Reduction of pain on injection of Propofol using meperidine and remifentanil. Eur. J. Anaesthesiol. 22, 890\u2013892. https:\/\/doi.org\/10.1017\/S0265021505231502 (2005).","journal-title":"Eur. J. Anaesthesiol."},{"key":"10015_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00540-017-2430-3","volume":"32","author":"X Li","year":"2018","unstructured":"Li, X. et al. Effect of Dexmedetomidine for Attenuation of Propofol injection pain in electroconvulsive therapy: a randomized controlled study. J. Anesth. 32, 70\u201376. https:\/\/doi.org\/10.1007\/s00540-017-2430-3 (2018).","journal-title":"J. Anesth."},{"key":"10015_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0140-6736(95)91209-6","volume":"346","author":"TM Bauer","year":"1995","unstructured":"Bauer, T. M. et al. Prolonged sedation due to accumulation of conjugated metabolites of Midazolam. Lancet 346, 145\u2013147. https:\/\/doi.org\/10.1016\/s0140-6736(95)91209-6 (1995).","journal-title":"Lancet"},{"key":"10015_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex, D. K. et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and Midazolam in patients undergoing colonoscopy. Gastrointest. Endosc. 88, 427\u2013437e6. https:\/\/doi.org\/10.1016\/j.gie.2018.04.2351 (2018).","journal-title":"Gastrointest. Endosc"},{"key":"10015_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi, M. et al. Efficacy and safety of remimazolam versus Propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase iib\/iii trial. J. Anesth. 34, 543\u2013553. https:\/\/doi.org\/10.1007\/s00540-020-02788-6 (2020).","journal-title":"J. Anesth."},{"key":"10015_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik, L. J., Goldwater, D. R., Kilpatrick, G. J., Tilbrook, G. S. & Borkett, K. M. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth. Analg. 115, 274\u2013283. https:\/\/doi.org\/10.1213\/ANE.0b013e31823f0c28 (2012).","journal-title":"Anesth. Analg"},{"key":"10015_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/01.anes.0000267503.85085.c0","volume":"107","author":"GJ Kilpatrick","year":"2007","unstructured":"Kilpatrick, G. J. et al. CNS 7056: A novel ultra-short-acting benzodiazepine. Anesthesiology 107, 60\u201366. https:\/\/doi.org\/10.1097\/01.anes.0000267503.85085.c0 (2007).","journal-title":"Anesthesiology"},{"key":"10015_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/phar.1806","volume":"36","author":"AM Wesolowski","year":"2016","unstructured":"Wesolowski, A. M., Zaccagnino, M. P., Malapero, R. J., Kaye, A. D. & Urman, R. D. Remimazolam: Pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy 36, 1021\u20131027. https:\/\/doi.org\/10.1002\/phar.1806 (2016).","journal-title":"Pharmacotherapy"},{"key":"10015_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","volume":"132","author":"J Sch\u00fcttler","year":"2020","unstructured":"Sch\u00fcttler, J. et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology 132, 636\u2013651. https:\/\/doi.org\/10.1097\/ALN.0000000000003103 (2020).","journal-title":"Anesthesiology"},{"key":"10015_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/ALN.0000000000003102","volume":"132","author":"A Eisenried","year":"2020","unstructured":"Eisenried, A., Sch\u00fcttler, J., Lerch, M., Ihmsen, H. & Jeleazcov, C. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology 132, 652\u2013666. https:\/\/doi.org\/10.1097\/ALN.0000000000003102 (2020).","journal-title":"Anesthesiology"},{"key":"10015_CR13","doi-asserted-by":"publisher","first-page":"109899","DOI":"10.1016\/j.jclinane.2020.109899","volume":"66","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J. Clin. Anesth. 66, 109899. https:\/\/doi.org\/10.1016\/j.jclinane.2020.109899 (2020).","journal-title":"J. Clin. Anesth."},{"key":"10015_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00540-022-03079-y","volume":"36","author":"K Masui","year":"2022","unstructured":"Masui, K., St\u00f6hr, T., Pesic, M. & Tonai, T. A population Pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice. J. Anesth. 36, 493\u2013505. https:\/\/doi.org\/10.1007\/s00540-022-03079-y (2022).","journal-title":"J. Anesth."},{"key":"10015_CR15","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1097\/00000539-200012000-00022","volume":"91","author":"RA Beers","year":"2000","unstructured":"Beers, R. A., Calimlim, J. R., Uddoh, E., Esposito, B. F. & Camporesi, E. M. A comparison of the cost-effectiveness of remifentanil versus Fentanyl as an adjuvant to general anesthesia for outpatient gynecologic surgery. Anesth. Analg. 91, 1420\u20131425. https:\/\/doi.org\/10.1097\/00000539-200012000-00022 (2000).","journal-title":"Anesth. Analg"},{"key":"10015_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft, D. W. & Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron 16, 31\u201341. https:\/\/doi.org\/10.1159\/000180580 (1976).","journal-title":"Nephron"},{"key":"10015_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10877-014-9643-x","volume":"29","author":"S Matsushita","year":"2015","unstructured":"Matsushita, S., Oda, S., Otaki, K., Nakane, M. & Kawamae, K. Change in auditory evoked potential index and bispectral index during induction of anesthesia with anesthetic drugs. J. Clin. Monit. Comput. 29, 621\u2013626. https:\/\/doi.org\/10.1007\/s10877-014-9643-x (2015).","journal-title":"J. Clin. Monit. Comput."},{"key":"10015_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/B:JOPA.0000012998.04442.1f","volume":"30","author":"L Zhang","year":"2003","unstructured":"Zhang, L., Beal, S. L. & Sheiner, L. B. Simultaneous vs. sequential analysis for population PK\/PD data I: best-case performance. J. Pharmacokinet. Pharmacodyn. 30, 387\u2013404. https:\/\/doi.org\/10.1023\/B:JOPA.0000012998.04442.1f (2003).","journal-title":"J. Pharmacokinet. Pharmacodyn"},{"key":"10015_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1023\/B:JOPA.0000012999.36063.4e","volume":"30","author":"L Zhang","year":"2003","unstructured":"Zhang, L., Beal, S. L. & Sheinerz, L. B. Simultaneous vs. sequential analysis for population PK\/PD data II: robustness of methods. J. Pharmacokinet. Pharmacodyn. 30, 405\u2013416. https:\/\/doi.org\/10.1023\/B:JOPA.0000012999.36063.4e (2003).","journal-title":"J. Pharmacokinet. Pharmacodyn"},{"key":"10015_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom, L., Pihlgren, P. & Jonsson, E. N. PsN-Toolkit\u2013a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput. Methods Programs Biomed. 79, 241\u2013257. https:\/\/doi.org\/10.1016\/j.cmpb.2005.04.005 (2005).","journal-title":"Comput. Methods Programs Biomed."},{"key":"10015_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s12630-024-02735-z","volume":"71","author":"S Yim","year":"2024","unstructured":"Yim, S. et al. Remimazolam to prevent hemodynamic instability during catheter ablation under general anesthesia: a randomized controlled trial. Can. J. Anaesth. 71, 1067\u20131077. https:\/\/doi.org\/10.1007\/s12630-024-02735-z (2024).","journal-title":"Can. J. Anaesth."},{"key":"10015_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/dmd.119.089680","volume":"48","author":"L Her","year":"2020","unstructured":"Her, L. & Zhu, H. J. Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators. Drug Metab. Dispos. 48, 230\u2013244. https:\/\/doi.org\/10.1124\/dmd.119.089680 (2020).","journal-title":"Drug Metab. Dispos."},{"key":"10015_CR23","doi-asserted-by":"publisher","first-page":"690875","DOI":"10.3389\/fphar.2021.690875","volume":"12","author":"GJ Kilpatrick","year":"2021","unstructured":"Kilpatrick, G. J. Remimazolam: Non-Clinical and clinical profile of a new sedative\/anesthetic agent. Front. Pharmacol. 12, 690875. https:\/\/doi.org\/10.3389\/fphar.2021.690875 (2021).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10015-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10015-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10015-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T19:55:54Z","timestamp":1752177354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10015-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10015"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10015-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors K. K. and M. K. were kindly gifted remimazolam, CNS-7054, and their internal standards from Paion UK Ltd. (Richmond, United Kingdom). Other authors have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Review Board of Ritsumeikan University Biwako-Kusatsu Campus (approval number BKC-IRB-2020-084) and the Ethical Review Committee of Yamagata University Faculty of Medicine (Approval number 2020\u2013284).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"24979"}}